PCMN
MRK icon

Paradigm Capital Management (Nevada)’s Merck MRK Stock Holding History

Paradigm Capital Management (Nevada)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.67M Sell
30,469
-500
-2% -$57.7K 3.36% 7
2025
Q4 		$3.26M Buy
30,969
+280
+0.9% +$26.3K 3.03% 8
2025
Q3 		$2.58M Buy
30,689
+1,329
+5% +$109K 2.55% 11
2025
Q2 		$2.32M Buy
29,360
+3,740
+15% +$297K 2.3% 11
2025
Q1 		$2.3M Buy
25,620
+1,449
+6% +$135K 2.35% 10
2024
Q4 		$2.4M Buy
24,171
+1,056
+5% +$109K 2.25% 11
2024
Q3 		$2.63M Buy
+23,115
New +$2.75M 2.52% 10
2022
Q4 		$2.66M Sell
23,957
-49
-0.2% -$5.01K 3.89% 7
2022
Q3 		$2.07M Sell
24,006
-591
-2% -$52.8K 2.75% 8
2022
Q2 		$2.24M Sell
24,597
-49
-0.2% -$4.34K 2.82% 9
2022
Q1 		$2.02M Buy
24,646
+1,725
+8% +$136K 2.04% 13
2021
Q4 		$1.76M Buy
+22,921
New +$1.83M 1.75% 16

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paradigm Capital Management (Nevada)'s MRK Position: Q1 2026 in Review

Paradigm Capital Management (Nevada) reduced its Merck (MRK) stake by 1.6% in Q1 2026, selling an estimated $57.7K and leaving 30,469 shares worth $3.67M. The position accounts for 3.36% of the portfolio, ranked #7.

Paradigm Capital Management (Nevada) first reported a position in MRK in Q4 2021 and has held it in 12 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Paradigm Capital Management (Nevada) held 30,469 shares of Merck worth $3.67M as of Q1 2026.
  • Paradigm Capital Management (Nevada) sold 500 Merck shares in Q1 2026, an estimated $57.7K.
  • Merck made up 3.36% of Paradigm Capital Management (Nevada)'s portfolio in Q1 2026, its #7 holding.
  • Paradigm Capital Management (Nevada) first reported a position in Merck in Q4 2021 and has held it in 12 quarters since.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Paradigm Capital Management (Nevada)'s 13F filing for Q1 2026, filed 6 May 2026.